Viral infections, including those caused by cytomegalovirus (CMV), Epstein-Barr virus (EBV) and BK virus (BKV) are an important cause of morbidity and mortality among transplant recipients. Recent advances in laboratory testing for these viruses have enhanced our ability to rapidly diagnose and manage these infections. Specifically, molecular testing allows healthcare providers to diagnose patients with viral infections, monitor their response to antiviral treatment, and potentially predict the most effective management strategies. In this webinar, Dr. Matt Binnicker (Director of Clinical Virology at Mayo Clinic, Rochester, MN) will highlight the clinical impact of viral infections in the transplant population and provide an overview of the laboratory methods that are available to assist in the diagnosis and management of these infections. Using a case-based approach, Dr. Binnicker will discuss the importance of using standardized protocols and assays, review the limitations and challenges associated with current diagnostic methods, and introduce future techniques, including the use of next-generation sequencing for determination of antiviral resistance.